Senior Scientist
Simulations Plus, Inc.
Lancaster, California
Dr. Priyata Kalra is a Senior Scientist in the Simulation Technologies R&D team for the Physiologically Based PharmacoKinetic (PBPK) Business Unit at Simulations Plus. At Simulations Plus, she leads the Read-Across PBPK project for chemicals and FDA project for building the IVIVE approach to predict the mucosal permeability of oral cavity drug products alongside supporting software development. She also serves as expert modeller on the European ECETOC Staged Assessment Taskforce and on European commission Designathon. Prior to joining Simulations Plus, she worked for three years at Bayer and BASF on PBPK, Quantitative Systems Pharmacology (QST) (for both small molecules and biologics) and IVIVE approaches in drug efficacy and toxicology. She earned her PhD from the University of Heidelberg, Germany, where she worked with Bayer Pharmaceuticals, focusing on QST models of biologics.
A passionate innovator at the intersection of machine learning, mathematics, and biomedicine, she is driven to bridge gaps between these disciplines. She leverages her multidisciplinary expertise to integrate ML/AI approaches with PBPK modeling as new approach methodologies (NAMs) for reducing animal studies. Her interests span data science, systems pharmacology, machine learning, design, crop science, blockchain, and entrepreneurship.
Disclosure information not submitted.
Practical Tips for Using GenAI in Biomedicine
Tuesday, October 22, 2024
3:00 PM – 4:00 PM MT